Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy
Status:
Completed
Trial end date:
2018-11-20
Target enrollment:
Participant gender:
Summary
The main drawbacks with oral iron are side-effects, poor compliance, and limited absorption
from the gut. It has become very apparent gastrointestinal intolerance with oral iron therapy
is dose related and common (up to 20% of patients), and this frequently leads to poor
compliance.
Lactoferrin (formerly known as lactotransferrin) is a glycoprotein, and a member of a
transferrin family, thus belonging to those proteins capable of binding and transferring
iron. It represents an attractive and promising alternative to ferrous sulphate oral
administration as pregnant women receiving lactoferrin did not experience any adverse
effects.
This study aims to compare between lactoferrin and ferrous sulphate for therapy of iron
deficiency in pregnant women.